LICENSES AND NOTICES

License for Use of "Physicians' Current Procedural Terminology", (CPT) Fourth Edition

End User/Point and Click Agreement: CPT codes, descriptions and other data only are copyright 2009 American Medical Association (AMA). All Rights Reserved (or such other date of publication of CPT). CPT is a trademark of the AMA.

You, your employees and agents are authorized to use CPT only as contained in the following authorized materials including but not limited to CGS fee schedules, general communications, Medicare Bulletin, and related materials internally within your organization within the United States for the sole use by yourself, employees, and agents. Use is limited to use in Medicare, Medicaid, or other programs administered by the Centers for Medicare & Medicaid Services (CMS). You agree to take all necessary steps to insure that your employees and agents abide by the terms of this agreement.

Any use not authorized herein is prohibited, including by way of illustration and not by way of limitation, making copies of CPT for resale and/or license, transferring copies of CPT to any party not bound by this agreement, creating any modified or derivative work of CPT, or making any commercial use of CPT. License to use CPT for any use not authorized here in must be obtained through the AMA, CPT Intellectual Property Services, 515 N. State Street, Chicago, IL 60610. Applications are available at the AMA websiteExternal Website.

This product includes CPT which is commercial technical data and/or computer data bases and/or commercial computer software and/or commercial computer software documentation, as applicable which were developed exclusively at private expense by the American Medical Association, 515 North State Street, Chicago, Illinois, 60610. U.S. Government rights to use, modify, reproduce, release, perform, display, or disclose these technical data and/or computer data bases and/or computer software and/or computer software documentation are subject to the limited rights restrictions of DFARS 252.227-7015(b)(2)(June 1995) and/or subject to the restrictions of DFARS 227.7202-1(a)(June 1995) and DFARS 227.7202-3(a)June 1995), as applicable for U.S. Department of Defense procurements and the limited rights restrictions of FAR 52.227-14 (June 1987) and/or subject to the restricted rights provisions of FAR 52.227-14 (June 1987) and FAR 52.227-19 (June 1987), as applicable, and any applicable agency FAR Supplements, for non-Department Federal procurements.

AMA Disclaimer of Warranties and Liabilities.

CPT is provided "as is" without warranty of any kind, either expressed or implied, including but not limited to, the implied warranties of merchantability and fitness for a particular purpose. AMA warrants that due to the nature of CPT, it does not manipulate or process dates, therefore there is no Year 2000 issue with CPT. AMA disclaims responsibility for any errors in CPT that may arise as a result of CPT being used in conjunction with any software and/or hardware system that is not Year 2000 compliant. No fee schedules, basic unit, relative values or related listings are included in CPT. The AMA does not directly or indirectly practice medicine or dispense medical services. The responsibility for the content of this file/product is with CGS or the CMS and no endorsement by the AMA is intended or implied. The AMA disclaims responsibility for any consequences or liability attributable to or related to any use, non-use, or interpretation of information contained or not contained in this file/product. This Agreement will terminate upon notice if you violate its terms. The AMA is a third party beneficiary to this Agreement.

CMS Disclaimer

The scope of this license is determined by the AMA, the copyright holder. Any questions pertaining to the license or use of the CPT must be addressed to the AMA. End Users do not act for or on behalf of the CMS. CMS DISCLAIMS RESPONSIBILITY FOR ANY LIABILITY ATTRIBUTABLE TO END USER USE OF THE CPT. CMS WILL NOT BE LIABLE FOR ANY CLAIMS ATTRIBUTABLE TO ANY ERRORS, OMISSIONS, OR OTHER INACCURACIES IN THE INFORMATION OR MATERIAL CONTAINED ON THIS PAGE. In no event shall CMS be liable for direct, indirect, special, incidental, or consequential damages arising out of the use of such information or material.

This license will terminate upon notice to you if you violate the terms of this license. The AMA is a third party beneficiary to this license.

POINT AND CLICK LICENSE FOR USE OF "CURRENT DENTAL TERMINOLOGY", ("CDT")

End User License Agreement

These materials contain Current Dental Terminology, Fourth Edition (CDT), copyright © 2002, 2004 American Dental Association (ADA). All rights reserved. CDT is a trademark of the ADA.

THE LICENSE GRANTED HEREIN IS EXPRESSLY CONDITIONED UPON YOUR ACCEPTANCE OF ALL TERMS AND CONDITIONS CONTAINED IN THIS AGREEMENT. BY CLICKING BELOW ON THE BUTTON LABELED "I ACCEPT", YOU HEREBY ACKNOWLEDGE THAT YOU HAVE READ, UNDERSTOOD AND AGREED TO ALL TERMS AND CONDITIONS SET FORTH IN THIS AGREEMENT.

IF YOU DO NOT AGREE WITH ALL TERMS AND CONDITIONS SET FORTH HEREIN, CLICK BELOW ON THE BUTTON LABELED "I DO NOT ACCEPT" AND EXIT FROM THIS COMPUTER SCREEN.

IF YOU ARE ACTING ON BEHALF OF AN ORGANIZATION, YOU REPRESENT THAT YOU ARE AUTHORIZED TO ACT ON BEHALF OF SUCH ORGANIZATION AND THAT YOUR ACCEPTANCE OF THE TERMS OF THIS AGREEMENT CREATES A LEGALLY ENFORCEABLE OBLIGATION OF THE ORGANIZATION. AS USED HEREIN, "YOU" AND "YOUR" REFER TO YOU AND ANY ORGANIZATION ON BEHALF OF WHICH YOU ARE ACTING.

  1. Subject to the terms and conditions contained in this Agreement, you, your employees, and agents are authorized to use CDT-4 only as contained in the following authorized materials and solely for internal use by yourself, employees and agents within your organization within the United States and its territories. Use of CDT-4 is limited to use in programs administered by Centers for Medicare & Medicaid Services (CMS). You agree to take all necessary steps to ensure that your employees and agents abide by the terms of this agreement. You acknowledge that the ADA holds all copyright, trademark and other rights in CDT-4. You shall not remove, alter, or obscure any ADA copyright notices or other proprietary rights notices included in the materials.
  2. Any use not authorized herein is prohibited, including by way of illustration and not by way of limitation, making copies of CDT-4 for resale and/or license, transferring copies of CDT-4 to any party not bound by this agreement, creating any modified or derivative work of CDT-4, or making any commercial use of CDT-4. License to use CDT-4 for any use not authorized herein must be obtained through the American Dental Association, 211 East Chicago Avenue, Chicago, IL 60611. Applications are available at the American Dental Association websiteExternal Website.
  3. Applicable Federal Acquisition Regulation Clauses (FARS)\Department of Defense Federal Acquisition Regulation Supplement (DFARS) Restrictions Apply to Government use. Please click here to see all U.S. Government Rights Provisions.
  4. ADA DISCLAIMER OF WARRANTIES AND LIABILITIES. CDT-4 is provided "as is" without warranty of any kind, either expressed or implied, including but not limited to, the implied warranties of merchantability and fitness for a particular purpose. No fee schedules, basic unit, relative values or related listings are included in CDT-4. The ADA does not directly or indirectly practice medicine or dispense dental services. The sole responsibility for the software, including any CDT-4 and other content contained therein, is with (insert name of applicable entity) or the CMS; and no endorsement by the ADA is intended or implied. The ADA expressly disclaims responsibility for any consequences or liability attributable to or related to any use, non-use, or interpretation of information contained or not contained in this file/product. This Agreement will terminate upon notice to you if you violate the terms of this Agreement. The ADA is a third-party beneficiary to this Agreement.
  5. CMS DISCLAIMER. The scope of this license is determined by the ADA, the copyright holder. Any questions pertaining to the license or use of the CDT-4 should be addressed to the ADA. End users do not act for or on behalf of the CMS. CMS DISCLAIMS RESPONSIBILITY FOR ANY LIABILITY ATTRIBUTABLE TO END USER USE OF THE CDT-4. CMS WILL NOT BE LIABLE FOR ANY CLAIMS ATTRIBUTABLE TO ANY ERRORS, OMISSIONS, OR OTHER INACCURACIES IN THE INFORMATION OR MATERIAL COVERED BY THIS LICENSE. In no event shall CMS be liable for direct, indirect, special, incidental, or consequential damages arising out of the use of such information or material.

The license granted herein is expressly conditioned upon your acceptance of all terms and conditions contained in this agreement. If the foregoing terms and conditions are acceptable to you, please indicate your agreement by clicking below on the button labeled "I ACCEPT". If you do not agree to the terms and conditions, you may not access or use the software. Instead, you must click below on the button labeled "I DO NOT ACCEPT" and exit from this computer screen.


Corporate

Print | Bookmark | Email | Font Size: + |

November 29, 2018

Targeted Probe and Educate Progress Update

The Centers for Medicare & Medicaid Services (CMS) Change Request 10249External PDF implemented the Targeted Probe & Educate (TPE) process, effective October 1, 2017. The following provides progress of TPE from October 1, 2017 – September 30, 2018.

Findings

Medical Review initiated complex review edits for specific providers identified through data analysis demonstrating high risk for improper payment. Education has been offered to providers throughout and upon completion of Round 1 of TPE review. Current Round 1 Home Health and Hospice Results are as follows:

Home Health

Probes completed July 1, 2018 – September 30, 2018

Eligibility and Medical Necessity edit 5A000

Results

Home Health

Probes Completed

122

Providers Compliant after Round 1 Completion

1

Providers Non-compliant after Round 1 Completion (advancing to Round 2)

121

Providers with Non-Reponses to ADR’s for Round 1

23

LOS >120 Days edit 5A002

Results

Home Health

Probes Completed

1

Providers Compliant after Round 1 Completion

0

Providers Non-compliant after Round 1 Completion (advancing to Round 2)

1

Providers with Non-Reponses to ADR’s for Round 1

0

LOS >180 Days edit 5A003

Results

Home Health

Probes Completed

1

Providers Compliant after Round 1 Completion

0

Providers Non-compliant after Round 1 Completion (advancing to Round 2)

1

Providers with Non-Reponses to ADR’s for Round 1

1

No response to ADR edit 5A004

Results

Home Health

Probes Completed

28

Providers Compliant after Round 1 Completion

0

Providers Non-compliant after Round 1 Completion (advancing to Round 2)

28

Providers with Non-Reponses to ADR’s for Round 1

19

Probes completed October 1, 2017 – September 30, 2018

Eligibility and Medical Necessity edit 5A000

Results

Home Health

Probes Completed

160

Providers Compliant after Round 1 Completion

4

Providers Non-compliant after Round 1 Completion (advancing to Round 2)

156

Providers with Non-Reponses to ADR’s for Round 1

32


LOS >120 Days edit 5A002

Results

Home Health

Probes Completed

1

Providers Compliant after Round 1 Completion

0

Providers Non-compliant after Round 1 Completion (advancing to Round 2)

1

Providers with Non-Reponses to ADR’s for Round 1

0

LOS >180 Days edit 5A003

Results

Home Health

Probes Completed

1

Providers Compliant after Round 1 Completion

0

Providers Non-compliant after Round 1 Completion (advancing to Round 2)

1

Providers with Non-Reponses to ADR’s for Round 1

1

No response to ADR edit 5A004

Results

Home Health

Probes Completed

40

Providers Compliant after Round 1 Completion

1

Providers Non-compliant after Round 1 Completion (advancing to Round 2)

39

Providers with Non-Reponses to ADR’s for Round 1

21

Findings by State

CGS is providing an overview of review findings by state for providers who have completed Round 1.

Screen Shot

Screen Shot

Risk Category

Risk Category is defined based on end of round provider error rate. The categories are defined as:

Screen Shot

Screen Shot

Screen Shot

Top Denial Reasons July 1 2018 – September 30, 2018

  1. Face-to-Face missing/incomplete/untimely
  2. Initial certification invalid
  3. Medical records were not received
  4. Recertification estimate missing/invalid
  5. Plan of care missing/invalid
  • FTF Documentation Denials accounted for approximately 25% of the total Targeted Probe and Educate denials.
    • Actual FTF encounter document not submitted
    • Certifying physician did not document the date of the FTF encounter
    • Community physician was not identified when a physician who would not be following the patient after discharge signed the certification
    • Required elements for initial certification (initial plan of care, initial certification, initial encounter documentation) were not submitted for recertification

      Refer to the CGS Home Health Coverage Guidelines Web page for a variety of resources on the home health FTF encounter.
  • Initial certification invalid accounted for approximately 13% of the total Targeted Probe and Educate denials.

    Refer to the CGS Home Health Physician Certification Web page for documentation tips and access to the Medicare Benefit Policy Manual (CMS Pub. 100-02, Ch. 7).
  • Medical records were not received accounted for approximately 11% of the total Targeted Probe and Educate denials.

    Refer to the CGS Medical Review Additional Development Request (ADR) Process Web page for information to ensure that necessary steps are taken to submit documentation timely.
  • Recertification estimate missing/invalid accounted for approximately 9% of the total Targeted Probe and Educate denials.
  • Plan of care missing/invalid accounted for approximately 7% of the total Targeted Probe and Educate denials.

    Refer to the CGS Physician Orders, Plan of Care and Certification and Home Health Missing/Incomplete/Untimely Plan of Care or CertificationPDF Web pages for documentation tips and access to the Medicare Benefit Policy Manual (CMS Pub. 100-02, Ch. 7).

Hospice

Probes completed July 1, 2018 – September 30, 2018

LOS with Non-Oncologic Diagnosis edit 5D000

Results

Hospice

Probes Completed

2

Providers Compliant after Round 1 Completion

0

Providers Non-compliant after Round 1 Completion (advancing to Round 2)

2

Providers with Non-Reponses to ADR’s for Round 1

0

Probes completed October 1, 2017 – September 30, 2018

LOS with Non-Oncologic Diagnosis edit 5D000

Results

Hospice

Probes Completed

2

Providers Compliant after Round 1 Completion

0

Providers Non-compliant after Round 1 Completion (advancing to Round 2)

2

Providers with Non-Reponses to ADR’s for Round 1

0

LOS >180 Days edit 5D002

Results

Hospice

Probes Completed

1

Providers Compliant after Round 1 Completion

0

Providers Non-compliant after Round 1 Completion (advancing to Round 2)

1

Providers with Non-Reponses to ADR’s for Round 1

0

LOS >120 Days edit 5D003

Results

Hospice

Probes Completed

1

Providers Compliant after Round 1 Completion

0

Providers Non-compliant after Round 1 Completion (advancing to Round 2)

1

Providers with Non-Reponses to ADR’s for Round 1

0

LOS in LTC, NF or SNF edit 5D004

Results

Hospice

Probes Completed

1

Providers Compliant after Round 1 Completion

0

Providers Non-compliant after Round 1 Completion (advancing to Round 2)

1

Providers with Non-Reponses to ADR’s for Round 1

0

Findings by State

CGS is providing an overview of review findings by state for providers who have completed Round 1.

Screen Shot

Screen Shot

Risk Category

Risk Category is defined based on end of round provider error rate. The categories are defined as:

Screen Shot

Screen Shot

Screen Shot

Top Denial Reasons July 1 2018 – September 30, 2018

  1. Terminal prognosis not supported
  2. MD services not medically necessary

Education

Providers with a moderate to high error rate will be offered an individualized education session where each claim found in error will be discussed and any questions will be answered. CGS offers education sessions via webinar, web-based presentation, or traditional teleconferences. Other methods may also be available. Providers may also submit questions or request education via the home health and hospice TPE email box at J15HHPROBEANDEDUCATION@CGSADMIN.COM.

Next Steps

Providers found to be non-compliant at the completion of Round 1 will advance to Round 2 of TPE at least 45 days from completion of the 1:1 post probe education call date. CGS offers education at any time for providers. Providers do not have to be identified for TPE to request education. CGS encourages providers to request education and conduct self-monitoring based on our posted Medical Review Activity Log and using tools such as Comparative Billing Reports (CBRs)PDF offered through our web portal.

References

26 Century Blvd Ste ST610, Nashville, TN 37214-3685 © CGS Administrators, LLC. All Rights Reserved